Objective The project addresses the problem of bone defect treatment. Using a marine alga ashydroxyapatite (HA) source, we aim to produce a fully biodegradable, bone growth-enhancing product, which can be used in any part of the skeleton to restore fully functional bones. This implant will be complete resorted and replaced by patients own, newly grown bone after a maximal period of 10 month, depending on the size of the implant. The main objectives are: - Cultivating the alga to ensure a permanent and high quality supply- Standardise the transformation process and develop a compacted form for more complicated areas- Integrate the HA in a carrier to simplify the application- Enrich the HA/carrier complex with bone growth factor and other medicines for long term release Prototype products will be tested on animals and humans equally, after ethical and legal considerations. Fields of science natural sciencesbiological sciencesmicrobiologyphycologymedical and health sciencesmedical biotechnologyimplantsartificial bone Programme(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Topic(s) 1.1.1.-5. - Key action Sustainable Agriculture, Fisheries and Forestry Call for proposal Data not available Funding Scheme EAW - Exploratory awards Coordinator N/A EU contribution No data Address See on map Total cost No data Participants (1) Sort alphabetically Sort by EU Contribution Expand all Collapse all DOLPHIN SEA VEGETABLE COMPANY United Kingdom EU contribution No data Address Glenwood business Centre UNIT 54, Sprinbank Indust BT17 0QL Dunmury - Belfast See on map Total cost No data